Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.
Researchers identify APOC1 and NOP16 as promising prostate cancer biomarkers that could aid early diagnosis. Learn more about ...
A novel electrode platform detects dopamine from single living brain organoids in real time, enabling non-destructive ...
This protozoan causes dysentery and is notoriously difficult to detect in archaeological samples because, unlike worms, it ...
KELOWNA, BC / ACCESS Newswire / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the follo ...
A new study published in the Indian Journal of Pediatrics showed that with seasonal and demographic variations, rotavirus ...
The Bureau of Fisheries and Aquatic Resources (BFAR) 13 (Caraga Region) issued a local advisory Thursday afternoon, warning ...
A new analysis of sewer drains from the Roman fort of Vindolanda, close to Hadrian's Wall, has shown that the occupants were ...
According to the USDA, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) ...
Just three days before officials announced that highly pathogenic avian influenza (HPAI) had popped up in a Wisconsin dairy ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback